At the present share price E4 approval + generic NuvaRing approval hopefully approved all being well this year , potential for these products plus Mayne being focused and established in the US , own major manufacturing plant etc . Most damage already done well reflected in the low share price way down from where it once was . Agree going forward from here there's a lot more going for it than against it .45 looks good value . Been here 5 years just hoping to recover most losses had enough but surprised at present share price not more investor interest , 3 leading brokers recommending sell wouldn't have helped , they have huge influence why shares rise or fall for no apparent reason .
MYX Price at posting:
44.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)